Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s 12-Month Price Target Currently Stands At 10
In last trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 1.5 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price